MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
SARS-CoV-2 and COVID-19 Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

4,166 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
4,166 works in the cohort · of 4,299,418page 53 of 84

Labels cover 17 of 4,166 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 4,166 of 4,166 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Auxiliary Screening COVID-19 by Serology
Xiongfeng Pan, Atipatsa Chiwanda Kaminga, Yuyao Chen, Hongying Liu, Shi Wu Wen, Yingjing Fang +2 more
2022· review· en· Frontiers in Public Health· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
afffundaboutunlabeled
COVID-19 vaccine effectiveness among South Asians in Canada
Rahul Chanchlani, Baiju R. Shah, Shrikant I. Bangdiwala, Russell J. de Souza, Jin Luo, Shelly Bolotin +9 more
2024· article· en· PLOS Global Public Health· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
aboutno affunlabeled
Virological characteristics of the SARS-CoV-2 XEC variant
Yu Kaku, Kaho Okumura, Shusuke Kawakubo, Keiya Uriu, Chen Luo, Yusuke Kosugi +10 more
2024· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Phase II/III Double-Blind Study Evaluating Safety and Immunogenicity of a Single Intramuscular Booster Dose of the Recombinant SARS-CoV-2 Vaccine “Patria” (AVX/COVID-12) Using an Active Newcastle Disease Viral Vector (NDV) during the Omicron Outbreak in Healthy Adults with Elevated Baseline Antibody Titers from Prior COVID-19 and/or SARS-CoV-2 Vaccination
Constantino López-Macı́as, Martha Torres, Brenda Armenta-Copca, Niels H. Wacher, Arturo Galindo‐Fraga, Laura Castro-Castrezana +33 more
2024· preprint· en· medRxiv· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
afffundaboutunlabeled
SARS-CoV-2 wildlife surveillance in Ontario and Québec, Canada
Janet E. Greenhorn, Jonathon D. Kotwa, Jeff Bowman, Laura L. Bruce, Tore Buchanan, Peter Buck +14 more
2021· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Medicine
machine prediction:candidate · noneconsensus · none
3
citations

How this was built: Screen · Findings · About